Amarin Corporation PLC Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 14 of 14 Posts
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
Healthcare And Biotechs Feel The Heat As The Market At New Highs
Article By: Tarun Chandra, CFA Wednesday, May 1, 2019 12:14 PM EDT
The stock market has continued to edge higher and the two major indexes, the Nasdaq (QQQ) and S&P 500 (SPY​), touched the all-time high milestone last week.
In this article: ACAD, ALXN, ARRY, AMRN, ARWR, AXSM, ASND
Read
Sideways Market Vexes Traders: Biotech Stocks Are Fading
Article By: Rod Raynovich Sunday, March 10, 2019 5:05 AM EDT
The 2019 rally is fading with few clues as to what comes next. The narrative gets more complicated once a slower global economic outlook gets factored into the fundamentals.
In this article: XLV, NITE, IBB, FBT, SPY, XBI, BIIB, IWM, GNMK, AMRN, TDOC
Read
Small Cap Biotechs Lead The Market In 2019 Up 20% YTD
Article By: Rod Raynovich Thursday, February 28, 2019 12:20 PM EDT
Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%.
In this article: ONCE, RARE, DHR, GE, XBI, BLUE, CRSP, IWM, XLV, MRK, RHHBY, BMY, CELG, LOXO, LLY, GNMK, AMRN, TDOC
Read
Amarin – 400% Growth And More On The Way
Article By: TipRanks Thursday, December 6, 2018 4:31 AM EDT
Amarin Corporation, Plc. is up 467% since the end of September. Really, that’s the only way to start a story on this small biopharmaceutical company.
In this article: AMRN
Read
Week In Review: Sinocare Eyes $4 Billion Deal For J&J Diabetes Device Business
Article By: ChinaBio® Today Saturday, January 20, 2018 5:34 PM EDT
Sinocare, a diabetes company based in Changsha, may bid as much as $4 billion to acquire Johnson & Johnson's diabetes medical device subsidiaries. With falling revenues, some of J&J's diabetes-focused companies are exiting from the US market.
In this article: JNJ, LLY, CELG, BGNE, MRTX, AMRN
Read
Here Are 5 ‘Strong Buy’ Stocks For Under $10
Article By: TipRanks Sunday, November 26, 2017 10:00 AM EDT
Cheap stocks can be a smart choice for investors, as there are serious bargains to be found. The stocks below may be cheap, but they all have significant support from Wall Street’s best-performing analysts.
In this article: CVU, AMRN, MCRB, CDNA, MRAM
Read
E ADRs Best & Worst Report - July 11, 2016
Article By: E.B. Capital Markets Monday, July 11, 2016 9:00 AM EDT
The average ADR is trading -23.76% below its 52 week high, 2.83% above its 200 dma, has 3.72 days to cover held short, and is expected to grow its EPS by 17.58% next year.
In this article: AXS, AZN, BCE, BMO, CEO, CNQ, ECA, GSK, HMY, KEP, KT, NVO, RDY, RY, SHI, SID, SNP, STO, TU, YZC, SUBCY, GOLD, GSOL, AMRN, DRD, GLPG
Read
Tuesday Morning’s Daily Insights: PHMD, AMRN, SGYP, And BBRY
Article By: TipRanks Tuesday, June 23, 2015 9:12 AM EDT
PhotoMedex Inc. shares soared 24.5% in pre-market trading to $2.29 after the dermatological pharmaceutical company announced it will be selling two treatments to MELA Sciences in a $42.5 million cash deal.
In this article: PHMD, AMRN, SGYP, BBRY (NOW BB)
Read
Strongest Stocks On StockTwits Last Week
Article By: Blair Jensen Thursday, March 19, 2015 1:42 PM EDT
Over the past week here are the stocks with the most bullish messages from the StockTwits community.
In this article: AMRN, TWTR, DIS, REGN, V, ORCL, ARNA, SBUX, FDX, MS, WFC, GM
Read
5 Great Buys
Article By: Jim Van Meerten Friday, March 13, 2015 6:18 AM EDT
After some spring cleaning last week I added back a few positions to our New High Portfolio. I added Foot Locker, Transportadora De Gas, Alliant Techsystems, Amarin and Citigroup .
In this article: FL, TGS, C, AMRN
Read
Week In Review: Eddingpharm Pays $169 Million For China Rights To Omega-3 Drug
Article By: ChinaBio® Today Sunday, March 1, 2015 5:52 PM EDT
Eddingpharm, a China in-licensing company, signed a deal worth up to $169 million for China rights to Vascepa®, a prescription omega-3 drug from Amarin Corp and more Pharma/Biotech news.
In this article: AMRN, ESALF, ESALY, TEVA
Read
Weakest Stocks On StockTwits And Twitter
Article By: Blair Jensen Wednesday, July 9, 2014 5:53 AM EDT
If you think this is the start of a larger correction now is the time to start looking at stocks that have been weak on StockTwits and Twitter.
In this article: DAL, JPM, LNKD, MCD, UAL, ARNA, Z, SNDK, AMRN, XONE
Read
Barchart Morning Call
Article By: Jim Van Meerten Monday, February 3, 2014 3:47 PM EDT
Covering the overnight markets and news you may have missed.
In this article: APC, CFN, CRI, DNB, EP, EV, EW, F, GGP, GS, HIG, HLF, MAT, NOC, PFG, SNN, SYY, TMK, YUM, NVDA, ORLY, AMRN
Read
1 to 14 of 14 Posts